Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-24

Clinical Trial Update: Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating sequential treatment with recombinant human thrombopoietin (rhTPO) followed by eltrombopag after glucocorticoids in adults wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eltrombopag (eltrombopag)
  • rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Primary Immune Thrombocytopenia (ITP) | Phase 4 | Status: NOT_YET_RECRUITING